Rosett Max has filed 7 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 207000 shares of Immunome Inc. ($IMNM) on July 29, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 29, 2025 | Immunome Inc. | $IMNM | Rosett Max | Chief Financial Officer | A | Employee Stock Option (right to buy) | 207000 | $0.00 | 207,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 19, 2024 | Immunome Inc. | $IMNM | Rosett Max | Chief Financial Officer | M | Common Stock | 42000 | $1.05 | 61,856.0000 | 0 | 211.52% | 0.00% |
| Sept. 19, 2024 | Immunome Inc. | $IMNM | Rosett Max | Chief Financial Officer | S | Common Stock | 14380 | $16.01 | 47,476.0000 | 0 | 23.25% | 0.00% |
| Sept. 19, 2024 | Immunome Inc. | $IMNM | Rosett Max | Chief Financial Officer | M | Stock option (right to buy) | 42000 | $0.00 | 91,848.0000 | 0 | 31.38% | 0.00% |
| Aug. 9, 2024 | Immunome Inc. | $IMNM | Rosett Max | EVP, Operations & CFO | A | Stock option (right to buy) | 190000 | $0.00 | 190,000.0000 | 0 | 9999.99% | 0.00% |
| May 16, 2024 | Immunome Inc. | $IMNM | Rosett Max | EVP, Operations & CFO | A | Stock option (right to buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Immunome Inc. | $IMNM | Rosett Max | EVP, OPERATIONS & INTERIM CFO | A | Stock option (right to buy) | 175000 | $0.00 | 175,000.0000 | 0 | 9999.99% | 0.00% |